Matching slides 110,471
Current window 75,841-75,870
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

75,841-75,870 of 110,471

filter-aware
13
The slide uses a process flow diagram to illustrate the clinical trial phases.Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
14
The slide uses a geographic map to visualize addressable market segments based on genetic prevalence data.Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Market Size1 hit
15
Aeglea BioTherapeutics | Investor Presentation Deck | 28 slidesAeglea BioTherapeutics | Investor Presentation Deck | 28 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
22
The slide outlines a sequential cohort design for a clinical trial, moving from IV to SC administration.Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
26
Includes a before/after microscopy image showing crystal clearance.Aeglea BioTherapeutics | Investor Presentation Deck | 28 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
27
Aeglea BioTherapeutics | Investor Presentation Deck | 28 slidesAeglea BioTherapeutics | Investor Presentation Deck | 28 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
04
BioNTech | Results Presentation Deck | 28 slidesBioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · Attention1 hit
08
BioNTech | Results Presentation Deck | 28 slidesBioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
11
Slide highlights key findings from a Nature publication regarding BNT111 vaccine efficacy and mechanism.BioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Includes process flow diagram, flow cytometry plots, and a scatter plot showing TCR frequency.BioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
The slide uses a visual representation of bispecific antibodies to explain their dual-target mechanism.BioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
Slide 15 of a BioNTech presentation, referencing SITC 2018.BioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
FIH = First-in-human; CPI = Checkpoint Inhibitor; ES-SCLC = Extensive-stage small cell lung cancer.BioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · Satisfaction1 hit
17
BioNTech | Results Presentation Deck | 28 slidesBioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · Satisfaction1 hit
24
BioNTech | Results Presentation Deck | 28 slidesBioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
27
The slide uses a table to map platforms to candidates, indications, and specific milestones, followed by a summary list of key newsflow events.BioNTech | Results Presentation Deck | 28 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
02
Broadridge Financial Solutions | Results Presentation Deck | 30 slidesBroadridge Financial Solutions | Results Presentation Deck | 30 slides · Broadridge
Deck Investor relations Beat · Attention1 hit
06
The slide highlights strong sales across multiple business segments and an 8% growth in recurring revenue backlog.Broadridge Financial Solutions | Results Presentation Deck | 30 slides · Broadridge
Deck Investor relations Beat · Need1 hit
06
Uses thermometer-style infographics to represent revenue magnitude.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
07
Uses a mobile app UI mockup to ground the abstract concept of tax complexity in a relatable user experience.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
09
Vertex | IPO Presentation Deck | 48 slidesVertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
11
The diagram is a hub-and-spoke model showing Vertex Solutions at the center of four key market segments.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
20
The chart shows a significant spike in ARR between 2019 and 2020.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
21
The timeline uses a custom layout to map product feature releases to ARR growth.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
24
The slide uses a horizontal spectrum to map market coverage by complexity. Vertex is positioned as covering the highest complexity segment.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
26
The image shows people arranged to form the letters '1K'.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
27
The slide uses a visual upward arrow background to imply growth.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
30
Vertex | IPO Presentation Deck | 48 slidesVertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
33
The slide uses a column-based framework to categorize pricing variables.Vertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit
43
Vertex | IPO Presentation Deck | 48 slidesVertex | IPO Presentation Deck | 48 slides · Vertex
Pitch deck Investment bank 1 hit